PL2550020T3 - Mikroemulsja odwróconych miceli zawierających jony metali i jej zastosowanie - Google Patents

Mikroemulsja odwróconych miceli zawierających jony metali i jej zastosowanie

Info

Publication number
PL2550020T3
PL2550020T3 PL11709950T PL11709950T PL2550020T3 PL 2550020 T3 PL2550020 T3 PL 2550020T3 PL 11709950 T PL11709950 T PL 11709950T PL 11709950 T PL11709950 T PL 11709950T PL 2550020 T3 PL2550020 T3 PL 2550020T3
Authority
PL
Poland
Prior art keywords
microemulsion
application
metal ions
containing metal
reverse micelles
Prior art date
Application number
PL11709950T
Other languages
English (en)
Inventor
Jean-Claude Maurel
Original Assignee
Medesis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma filed Critical Medesis Pharma
Publication of PL2550020T3 publication Critical patent/PL2550020T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
PL11709950T 2010-03-24 2011-03-24 Mikroemulsja odwróconych miceli zawierających jony metali i jej zastosowanie PL2550020T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31702410P 2010-03-24 2010-03-24
EP10305298 2010-03-24
EP11709950.7A EP2550020B1 (en) 2010-03-24 2011-03-24 Reverse micelle microemulsion comprising metal ions and use thereof
PCT/EP2011/054511 WO2011117333A2 (en) 2010-03-24 2011-03-24 Reverse micelle system comprising metal ions and use thereof

Publications (1)

Publication Number Publication Date
PL2550020T3 true PL2550020T3 (pl) 2015-12-31

Family

ID=43859634

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11709950T PL2550020T3 (pl) 2010-03-24 2011-03-24 Mikroemulsja odwróconych miceli zawierających jony metali i jej zastosowanie

Country Status (8)

Country Link
US (1) US9592218B2 (pl)
EP (1) EP2550020B1 (pl)
CA (1) CA2792136C (pl)
DK (1) DK2550020T3 (pl)
ES (1) ES2548681T3 (pl)
PL (1) PL2550020T3 (pl)
PT (1) PT2550020E (pl)
WO (1) WO2011117333A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10384178B2 (en) * 2012-06-29 2019-08-20 Archer Daniel Midland Company Microemulsions and uses thereof as nanoreactors or delivery vehicles
JP6051015B2 (ja) * 2012-10-30 2016-12-21 ポーラ化成工業株式会社 ベシクル分散水溶液及び該ベシクル分散水溶液を含有する皮膚外用組成物
WO2015059193A1 (en) * 2013-10-22 2015-04-30 Medesis Pharma Organogel formulation and uses thereof
EA037605B1 (ru) * 2014-02-18 2021-04-20 Медзис Фарма Применение обратно-мицеллярных систем для доставки реагентов, хелатирующих радионуклиды и металлы
WO2017005899A1 (en) 2015-07-09 2017-01-12 Medesis Pharma In situ preparation of cyano-bridged metal nanop articles within a biocompatible reverse micellar system
BR112021000121A2 (pt) 2018-07-06 2021-04-06 Medesis Pharma Tratamento e prevenção de lesões devido a exposição à radiação
WO2023025899A2 (en) * 2021-08-26 2023-03-02 Transgene Delivery system for targeting genes of the interferon pathway
WO2024184369A1 (en) 2023-03-06 2024-09-12 Medesis Pharma Formulation for the buccal administration of a biocompatible reverse micelle system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
WO1995020945A1 (en) * 1994-02-04 1995-08-10 Scotia Lipidteknik Ab Lipophilic carrier preparations
FR2729957B1 (fr) 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
FR2750606B1 (fr) 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
US6040188A (en) * 1997-11-18 2000-03-21 The Regents Of The University Of California In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants
GB2368521B (en) 2000-10-31 2004-12-08 Jasali Ltd Pharmaceutical or dietary composition containing a vegetable oil in particular olive oil and sitosterol
EP1452175A1 (en) 2003-02-28 2004-09-01 Medesis Pharma S.A. Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
EP1652513A1 (en) 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof
EP1652512A1 (en) 2004-11-02 2006-05-03 Medesis Pharma Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
MX2010003642A (es) * 2007-10-12 2010-08-09 Massachusetts Inst Technology Nanotecnologia de vacuna.

Also Published As

Publication number Publication date
WO2011117333A2 (en) 2011-09-29
CA2792136C (en) 2020-08-04
US9592218B2 (en) 2017-03-14
US20130052279A1 (en) 2013-02-28
EP2550020A2 (en) 2013-01-30
WO2011117333A3 (en) 2012-06-07
PT2550020E (pt) 2015-10-20
ES2548681T3 (es) 2015-10-20
EP2550020B1 (en) 2015-07-08
CA2792136A1 (en) 2011-09-29
DK2550020T3 (en) 2015-10-05

Similar Documents

Publication Publication Date Title
SMT201600276B (it) Idrossido metallico ossidato misto e procedimento di produzione dello stesso
PL2848708T3 (pl) Drogi obróbki tytanu i stopy tytanu
PL2578711T3 (pl) Blacha stalowa i sposób jej wytwarzania
SMT201600021B (it) Nuovi composti di chinolina sostituiti come inibitori della s-nitrosoglutatione reduttasi
FR23C1001I2 (fr) Composition de facteur vii
GB201407437D0 (en) Discovery-based indentification and migration of easily cloudifiable applications
EP2714970A4 (en) Enzyme QUANTIFICATION
PL2903754T3 (pl) Łyżka i jej zastosowanie
PL2729151T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
FR2963356B1 (fr) Structure de securite incorporant des compositions phosphorescente et fluorescente
CO6980141A1 (es) Compuestos y composiciones de poliglicerilo catónicos
IL223341A (en) Aqueous alkaline cleaning compositions and methods of their use
EP2687597A4 (en) MODIFIED LPHA GLUCOSIDASE AND APPLICATIONS THEREOF
IL215681A (en) Reducing formation of oxide on solder
PL2773197T3 (pl) Przeciwdrobnoustrojowa kompozycja jonomerowa i jej zastosowania
DK2800572T3 (da) Sammensætning af ellagitannin-rige ekstrakter
EP2629758A4 (en) METAL ION NANO CLUSTER
PL2586085T3 (pl) Sposób wytwarzania mieszanych tlenków metali i litu i ich zastosowanie jako materiału katodowego
PL2834183T3 (pl) Zespół suwnicy pomostowej i sposób jej montażu
EP2912278A4 (en) REDUCTION OF EXCITEMENT OF DISTANCE TO TURBINE GUIDES
GB201100259D0 (en) Management of pool member configuration
SMT201700079B (it) Composto di benzopirano deuterato e sua applicazione
PT2550020E (pt) Microemulsão de micelas reversas compreendendo iões metálicos e sua utilização
DK2665793T3 (da) Azeotroplignende sammensætninger af trans-1,1,1,4,4,4-hexafluor-2-buten og vand
IT1403611B1 (it) Composizione di poliesteri